## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- last_verified: "2026-06-01T08:26:16.004Z" --- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "Mosby’s Nursing Drug Reference" developer_entity: "Skyscape Medpresso Inc" bundle_id: "com.medpresso.Lonestar.rndrug" app_store_id: "1145789975" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-02-01" report_date: "2026-06-01" last_verified: "2026-06-01" report_version: "5.8.5" total_reviews: 262 overall_rating: 4.04 confidence: "low" confidence_score: 0.65 data_age_days: 0 intelligence_version: 3 nemesis: "Nursing Central" competitor_count: 7 tags: ["medical", "subscription", "mobile app", "app review", "app analysis", "nursing", "students", "practicing"] canonical_url: "https://marlvel.ai/intel-report/medical/mosby-s-nursing-drug-reference" license: "CC-BY-NC 4.0" content_version: "v2" --- # Mosby’s Nursing Drug Reference App Audit ## TL;DR {#tldr} - **Category**: Medical · Subscription - **Signal**: Rating 4.04 > **TL;DR:** Mosby’s Nursing Drug Reference is a medical app by Skyscape Medpresso Inc, rated 4.04/5 by 262 users, available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** Mosby’s Nursing Drug Reference is a medical app by Skyscape Medpresso Inc. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 4.04/5 (262 reviews) | | **Category** | Medical | | **Developer** | Skyscape Medpresso Inc | | **Pricing** | Subscription | | **Platforms** | iOS & Android | | **Confidence** | Low (0.65/1.0) | | **Data Age** | 0d | ## Metadata & Market Performance - **Publisher:** Skyscape Medpresso Inc - **Category:** Medical - **Target Audience:** Nursing students and practicing clinicians requiring rapid, evidence-based drug information and safety alerts during clinical rotations. - **Platforms:** iOS & Android - **Version Audited:** 5.8.5 - **Audit Date:** 2026-06-01 - **Signal Count:** 262 reviews analyzed - **Confidence:** Low (0.65/1.0) - **App Store ID (iOS):** 1145789975 - **Bundle ID:** com.medpresso.Lonestar.rndrug - **Google Play ID:** com.medpresso.Lonestar.rndrug - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-06-01 ## Executive Snapshot **What it is:** Mosby’s Nursing Drug Reference is a clinical pharmacology tool for nursing students and clinicians, providing drug monographs and medical calculators on iOS and Android. **Why users hire it:** Users hire this app to minimize medication dispensing errors through verified safety alerts, replacing the need for bulky printed handbooks during clinical rotations. ## App DNA (Features & Intent) - **[Standard] Drug Monographs:** Access to 5,000+ generic and trade name drug profiles including FDA-approved entries * *User Intent:* Users seek enhanced value through premium features. - **[Differentiator] Safety Alert Icons:** Visual indicators for critical interactions and side effects within drug monographs * *User Intent:* Users want timely prompts to stay engaged without missing updates. - **[Differentiator] Built-in Calculators:** 26 specialized medical calculators for clinical decision support ## Market Position {#market-position} The app maintains a #80 Grossing rank in the US Medical category, but the 3.4-star rating on Android indicates significant friction compared to the iOS experience. This performance gap suggests that technical instability on Android is actively eroding the app's professional credibility. ## Monetization Strategy - **Model:** Subscription - **Tiers:** Free app with sample content, Yearly auto-renewing subscription at $44.99 for full content access - **Analysis:** Subscription model anchored at $44.99/year, gating full clinical database access behind an annual recurring payment. ## SWOT Analysis {#swot} **Core Strengths:** - Safety Alert icons function as a clinical trust moat - Nursing Process framework aligns with academic curriculum requirements **Critical Frictions:** - $44.99/year subscription price exceeds free-tier utility of Medscape - 3.4 rating on Android suggests stability issues **Growth Levers:** - Integration of wearable-based clinical alerts - B2B partnerships with nursing schools for bulk license distribution **Market Threats:** - UpToDate’s institutional dominance limits professional growth - Medscape’s free, multi-disciplinary model drains the casual-user funnel ## Recent Changes (v2 → v3) {#recent-changes} The app has transitioned to a rigid $44.99 annual subscription model while facing significant technical instability on Android, which is eroding its competitive standing against free, multi-disciplinary clinical tools. **Overall trend**: Mixed **Compared at**: 2026-06-01 ### High-impact changes - **[Shifted] Subscription Model Formalization** (pricing) — Pricing shifted from an undefined freemium model to a $44.99/year auto-renewing subscription. - **[Declined] Android Technical Instability** (sentiment) — New data indicates a 3.4-star rating on Android, signaling technical friction that is absent in the iOS experience. ### Medium-impact changes - **[Improved] Feature Repositioning** (features) — Safety Alert icons and clinical calculators were upgraded from 'standard' to 'differentiator' status. - **[Added] Competitive Threat Identification** (swot) — Added UpToDate and Medscape as primary threats, noting their institutional dominance and free-tier utility respectively. ## Rivals Landscape {#rivals} > Competitive positioning identified by AI analysis of app features, category, and market signals. ### Mosby’s Nursing Drug Reference vs Nursing Central — Head to Head - **[Nursing Central](https://marlvel.ai/intel-report/medical/com-unboundmedicine-nursingcentral)** by Unbound Medicine, Inc.: This is the most direct competitor, offering a comprehensive nursing-specific drug reference suite that mirrors the target's core value proposition. - **Moat strength:** High — sustainable advantage over 12 months - **Key differences:** - Integrates multiple nursing-specific databases beyond just drug references into a single unified clinical workflow tool. - Provides cross-linked access to disease, test, and procedure information which the target app currently lacks. - Maintains a consistent, high-frequency update cycle for clinical content that builds long-term professional trust. - **Where Mosby’s Nursing Drug Reference wins:** - ✅ Offers a lower barrier to entry with a free-to-download model and sample content for immediate evaluation. - ✅ Provides a specialized focus on drug-specific calculators that streamlines the medication administration workflow for nurses. - **Where Nursing Central wins:** - ❌ Bundles comprehensive disease and diagnostic references, creating a broader clinical utility that encourages daily app retention. - ❌ Leverages a long-standing reputation for clinical accuracy that serves as a primary reference for nursing students. - **Verdict:** The target must pivot from a standalone drug reference to a broader clinical decision support tool to prevent user migration to Nursing Central's all-in-one ecosystem. ### Contenders (Strong Challengers) - **[Davis's Drug Guide for Nurses](https://marlvel.ai/intel-report/medical/davis-s-drug-guide-for-nurses)** by AtmosphereApps [Moat: Medium]: A direct thematic competitor specifically targeting the nursing drug reference market with high user satisfaction. - Features a highly specialized nursing-focused drug guide that directly competes with Mosby's core content. - Optimized for quick-reference lookup during clinical shifts, prioritizing speed over the target's broader feature set. - **[Medscape](https://marlvel.ai/intel-report/medical/medscape)** by WebMD [Moat: High]: A massive, multi-disciplinary medical platform that captures the broader professional audience the target app serves. - Provides a massive, free, and constantly updated drug database that makes paid standalone references harder to justify. - Includes clinical news, CME credits, and professional networking features that create a powerful daily-use habit. ### Peers (What They Do Better) - **[UpToDate](https://marlvel.ai/intel-report/medical/uptodate)** by UpToDate, Inc.: The gold standard for clinical decision support, serving as the ultimate reference for the target's professional audience. - Offers evidence-based clinical content that is widely considered the industry standard for physician and nurse decision-making. - Operates on a high-value institutional subscription model that creates significant barriers to entry for smaller apps. - **[Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10)** by Doximity: Dominates the professional networking and clinical communication space, capturing significant time from the target's user base. - Facilitates secure clinical communication and telehealth, shifting the app's utility from reference to active clinical workflow. - Leverages a massive professional network to drive engagement through career, news, and peer-to-peer connection features. - **[Calculate by QxMD](https://marlvel.ai/intel-report/medical/calculate-by-qxmd)** by WebMD: Focuses on the clinical calculation utility that is a secondary feature of the target app. - Specializes in highly specific clinical decision rules and calculators that outperform general-purpose drug reference app tools. - Provides a streamlined, utility-first interface that minimizes the time required to reach a clinical calculation result. ### New Kids on the Block (What's Innovative) - **[NCLEX RN Mastery Exam - 2026](https://marlvel.ai/intel-report/medical/com-higherlearning-nclex)** by Higher Learning Technologies: Captures the student segment of the nursing market with high-frequency updates and exam-focused content. ## App Momentum (Steady) {#momentum} - Added 35 FDA-approved drug monographs. - Improved memory management for launch speeds. ## The "So What?" (Strategic Takeaway) {#so-what} Mosby’s Nursing Drug Reference is an established medical app that is available. With a 4.04/5 rating from 262 reviews, it shows polarized user reception. > **Bottom Line:** The app maintains clinical authority through specialized safety alerts, but the high $44.99 price point and Android technical instability invite migration to free alternatives, so the PM must prioritize platform parity to defend the existing user base. **Best for:** Nursing students and practicing clinicians requiring rapid, evidence-based drug information and safety alerts during clinical rotations. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] [HIGH IMPACT] Rebuild Android core to match iOS stability because the 3.4 rating indicates technical churn → recover Android user base — *Android rating is significantly lower than iOS, creating a barrier to professional adoption.* _(trade-off: deprioritize Pause the Evolve-only monograph expansion — stability is a higher churn risk than content volume.)_ - [ ] [PIVOT] [MEDIUM IMPACT] Audit the $44.99 annual price point against Medscape's free model because conversion data suggests price sensitivity → reduce abandonment — *Medscape's free, multi-disciplinary model makes paid standalone references harder to justify.* _(trade-off: deprioritize Defer the new clinical calculator development — pricing alignment is more critical for long-term retention.)_ ### Feature Gaps vs Competitors - Cross-linked disease and diagnostic references (available in Nursing Central but absent here) - Professional networking and clinical communication features (available in Doximity but absent here) ### Outlook: Mixed The medical reference market is consolidating around free, multi-disciplinary platforms that offer broader utility than standalone drug guides. Mosby's must transition from a static reference tool to a workflow-integrated clinical assistant to prevent further user migration to all-in-one competitors. - 🔴 Android technical instability (3.4 rating) creates a barrier to professional adoption, which compounds the churn risk against free competitors. - 🟢 The addition of 35 FDA-approved monographs demonstrates active clinical content maintenance, which sustains the app's value for current subscribers. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 4.04/5 | | Total Reviews | 262 | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **Mosby’s Nursing Drug Reference** (this app) | 4.04/5 | N/A | Skyscape Medpresso Inc | | [NCLEX RN Mastery Exam - 2026](https://marlvel.ai/intel-report/medical/com-higherlearning-nclex) | 4.8/5 | N/A | Higher Learning Technologies | | [Doximity](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) | 4.8/5 | N/A | Doximity | | [Nursing Central](https://marlvel.ai/intel-report/medical/com-unboundmedicine-nursingcentral) | 4.9/5 | N/A | Unbound Medicine, Inc. | | [UpToDate](https://marlvel.ai/intel-report/medical/uptodate) | 4.3/5 | N/A | UpToDate, Inc. | | [Medscape](https://marlvel.ai/intel-report/medical/medscape) | 3.7/5 | N/A | WebMD | ## Company Profile - **Developer:** Skyscape Medpresso Inc - **Website:** [https://www.skyscape.com/product/mosbys-2018-nursing-drug-reference](https://www.skyscape.com/product/mosbys-2018-nursing-drug-reference) - **Social:** [Instagram](https://instagram.com/skyscapeinc) · [Facebook](https://www.facebook.com/skyscapeinc) · [X/Twitter](https://twitter.com/skyscapeinc) · [YouTube](https://www.youtube.com/watch) · [LinkedIn](https://www.linkedin.com/in/sandeep131) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/mosbys-nursing-drug-reference/id1145789975?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.medpresso.Lonestar.rndrug&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.skyscape.com/product/mosbys-2018-nursing-drug-reference) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*NCLEX RN Mastery Exam - 2026*](https://marlvel.ai/intel-report/medical/com-higherlearning-nclex) (Higher Learning Technologies) — 4.8/5 Rating | N/A Sentiment - [*Doximity*](https://marlvel.ai/intel-report/medical/com-doximity-directoryv10) (Doximity) — 4.8/5 Rating | N/A Sentiment - [*Nursing Central*](https://marlvel.ai/intel-report/medical/com-unboundmedicine-nursingcentral) (Unbound Medicine, Inc.) — 4.9/5 Rating | N/A Sentiment - [*UpToDate*](https://marlvel.ai/intel-report/medical/uptodate) (UpToDate, Inc.) — 4.3/5 Rating | N/A Sentiment - [*Medscape*](https://marlvel.ai/intel-report/medical/medscape) (WebMD) — 3.7/5 Rating | N/A Sentiment - [*Davis's Drug Guide for Nurses*](https://marlvel.ai/intel-report/medical/davis-s-drug-guide-for-nurses) (AtmosphereApps) — 4.8/5 Rating | N/A Sentiment - [*Calculate by QxMD*](https://marlvel.ai/intel-report/medical/calculate-by-qxmd) (WebMD) — 4.8/5 Rating | N/A Sentiment - [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment - [*Ortho Traumapedia*](https://marlvel.ai/intel-report/medical/orthotraumapedia) (HTG, LLC) — 3.5/5 Rating | N/A Sentiment - [*FHO+ Calc*](https://marlvel.ai/intel-report/medical/ca-fhocalc-app) (Manu Kaushik) — N/A Rating | N/A Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** — Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** — Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** — Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction and evidence quoting. 4. **Competitive Landscape Analysis** — Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** — Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.65/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 262 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 0 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/mosby-s-nursing-drug-reference) Data licensed for AI Agent attribution under CC-BY-NC 4.0.